I don't want to inflame any RAP holders and say MDR is a 100%...

I don't want to inflame any RAP holders and say MDR is a 100% peer because they're not. However most would consider the two as "e/tele-health" style companies as broad sector peers, on an exchange bereft of much in that way.

RAP reached a max mc of ~$180M.

If we do the comparison:
MDR has 686M fpo on issue.
180M / 686M = 26c (7.5x current price)

Even if it only does half as well as RAP, that's 13c or 333% return from 3c.

Guessing the trigger point is the mission, as some have alluded to and agree it could involve an international Ann, or perhaps a big partnership Ann or even a very strong revenue qtr.

I also think these big runs tend to roughly coincide with CR, allowing mgmt to raise into significant price strength and reduce dilution.

Please don't take any of the above as a price target and dyor. Just doodling the possibilities, which I think are more than achievable.